Displaying drugs 2026 - 2050 of 2319 in total
PM02734
PM02734 is a marine derived compound. PM02734 as a new antiproliferative drug demonstrating activity against a broad spectrum of tumor types: breast, colon, pancreas, lung and prostate, among others.
Investigational
Matched Description: … PM02734 is a marine derived compound. ... PM02734 as a new antiproliferative drug demonstrating activity against a broad spectrum of tumor types …
Turnera diffusa leaf
Turnera diffusa leaf is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Experimental
Matched Description: … Turnera diffusa leaf is a plant/plant extract used in some OTC (over-the-counter) products. …
EGEN-001
EGEN-001 is a novel non-viral vector consisting of a plasmid DNA encoding the human gene for interleukin 12 (IL-12) and a biocompatible, biodegradable delivery polymer with potential antineoplastic activity.
Investigational
Matched Description: … EGEN-001 is a novel non-viral vector consisting of a plasmid DNA encoding the human gene for interleukin ... 12 (IL-12) and a biocompatible, biodegradable delivery polymer with potential antineoplastic activity …
Taberminogene vadenovec
Taberminogene vadenovec (EG004) is a novel product consisting of a local delivery device and a gene-based medicine, being developed to prevent the blocking of veins and arteries that frequently occurs after vascular surgery. The initial target market is haemodialysis graft access surgery, a procedure in which patients whose kidneys have...
Investigational
Matched Description: … Taberminogene vadenovec (EG004) is a novel product consisting of a local delivery device and a gene-based ... their blood can be regularly filtered using a dialysis machine. ... The initial target market is haemodialysis graft access surgery, a procedure in which patients whose …
Oportuzumab monatox
VB4-845 is studied in the treatment of certain types of head and neck cancer. VB4-845 is made by linking a monoclonal antibody fragment to a toxic protein that may kill cancer cells. VB4-845 is a fusion protein containing humanized scFv specific for the epithelial cell adhesion molecule, Ep-CAM, a tumor...
Investigational
Matched Description: … a truncated portion of Pseudomonas exotoxin A. ... VB4-845 is made by linking a monoclonal antibody fragment to a toxic protein that may kill cancer cells ... , Ep-CAM, a tumor cell-associated target highly expressed on carcinoma cells of epithelial origin and …
DengueCide
DengueCide is a nonjugate of a dengue virus specific small chemical ligand and an amphiphilic PEG based polymer
Investigational
Matched Description: … DengueCide is a nonjugate of a dengue virus specific small chemical ligand and an amphiphilic PEG based …
Cemdisiran
Cemdisiran is under investigation in clinical trial NCT03841448 (A Study of Cemdisiran in Adults With Immunoglobulin a Nephropathy (Igan)).
Investigational
Matched Description: … Immunoglobulin a Nephropathy (Igan)). ... Cemdisiran is under investigation in clinical trial NCT03841448 (A Study of Cemdisiran in Adults With …
SIG-007
SIG-007 is a gene therapy that consists of cells that are genetically modified with a non-viral vector to express human alpha-galactosidase A. Developed by Sigilon Therapeutics, t is being investigated for the treatment of Fabry Disease.
Investigational
Matched Description: … SIG-007 is a gene therapy that consists of cells that are genetically modified with a non-viral vector ... to express human alpha-galactosidase A. …
Pinus densiflora whole
Experimental
BVX001
BVX001 is a a novel, first-in-class CD33/CD7-directed antibody-drug conjugate.
Investigational
Matched Description: … BVX001 is a a novel, first-in-class CD33/CD7-directed antibody-drug conjugate. …
Cytochrome C
Cytochrome C is a hemeprotein that plays a role in the mitochondrial electron-transport chain.
Investigational
Matched Description: … Cytochrome C is a hemeprotein that plays a role in the mitochondrial electron-transport chain. …
MTL-CEBPA
MTL-CEBPA is a SMARTICLES liposomal formulation of MTL-501, a small activating RNA (saRNA) oligonucleotide.
Investigational
Matched Description: … MTL-CEBPA is a SMARTICLES liposomal formulation of MTL-501, a small activating RNA (saRNA) oligonucleotide …
Sodium metabisulfite
Experimental
Ribaxamase
Ribaxamase is under investigation in clinical trial NCT02563106 (A Study of SYN-004 for the Prevention of c.diff in Patients With a LRTI).
Investigational
Matched Description: … of c.diff in Patients With a LRTI). ... Ribaxamase is under investigation in clinical trial NCT02563106 (A Study of SYN-004 for the Prevention …
Emerfetamab
Emerfetamab is a bispecific T cell engager antibody construct with a half-life extension Fc moiety capable of binding to the neonatal Fc receptor.
Investigational
Matched Description: … Emerfetamab is a bispecific T cell engager antibody construct with a half-life extension Fc moiety capable …
trans NV-04
trans NV-04 is a cardiovascular drug which shows a significant reduction in blood pressure and arterial stiffness.
Investigational
Matched Description: … trans NV-04 is a cardiovascular drug which shows a significant reduction in blood pressure and arterial …
SL017
SL017 formulated as a topical gel, has been combined with a widely available light source for permanent removal of unwanted hair and for treatment of actinic keratosis
Investigational
Matched Description: … SL017 formulated as a topical gel, has been combined with a widely available light source for permanent …
KB001
KB001 is a Humaneered™ PEGylated monoclonal antibody fragment for the treatment of life-threatening Pseudomonas aeruginosa infections, a common problem of cystic fibrosis and mechanically ventilated patients.
Investigational
Matched Description: … KB001 is a Humaneered™ PEGylated monoclonal antibody fragment for the treatment of life-threatening ... Pseudomonas aeruginosa infections, a common problem of cystic fibrosis and mechanically ventilated patients …
Contulakin-G
Contulakin-G is a broad spectrum non-opioid analgesic. It is the synthetic form of a natural peptide extracted from the venom of the Conus Geographus sea snail.
Investigational
Matched Description: … Contulakin-G is a broad spectrum non-opioid analgesic. ... It is the synthetic form of a natural peptide extracted from the venom of the Conus Geographus sea snail …
Sepofarsen
Sepofarsen is under investigation in clinical trial NCT03913143 (A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE)).
Investigational
Matched Description: … , Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE)). ... Sepofarsen is under investigation in clinical trial NCT03913143 (A Study to Evaluate Efficacy, Safety …
SB-559448
SB-559448 is a small-molecule drug that mimics the activity of thrombopoietin (TPO), a protein factor that promotes growth and production of blood platelets. This drug is developed by GlaxoSmithKline and used to treat Thrombocytopenia.Thrombocytopenia (decreased platelet count) is a common side effect of many chemotherapies and can lead to uncontrolled...
Investigational
Matched Description: … SB-559448 is a small-molecule drug that mimics the activity of thrombopoietin (TPO), a protein factor ... common side effect of many chemotherapies and can lead to uncontrolled bleeding, thus representing a ... by GlaxoSmithKline and used to treat Thrombocytopenia.Thrombocytopenia (decreased platelet count) is a …
MLN0415
MLN0415 is a novel, small molecule IKK2 inhibitor, discovered by Millennium scientists. In preclinical studies, MLN0415 was shown to decrease NF-kB activation and down-regulate the expression of a number of inflammatory proteins. Because inflammatory proteins play a critical role in inflammation and drive the inflammatory response to disease, controlling these...
Investigational
Matched Description: … MLN0415 is a novel, small molecule IKK2 inhibitor, discovered by Millennium scientists. ... Because inflammatory proteins play a critical role in inflammation and drive the inflammatory response ... preclinical studies, MLN0415 was shown to decrease NF-kB activation and down-regulate the expression of a …
Mongersen
Mongersen is under investigation in clinical trial NCT02957474 (A Study to Evaluate the Effect of Food, Formulation Strength, and a Proton Pump Inhibitor on GED 0301 Pharmacokinetics in Healthy Adult Subjects).
Investigational
Matched Description: … Mongersen is under investigation in clinical trial NCT02957474 (A Study to Evaluate the Effect of Food ... , Formulation Strength, and a Proton Pump Inhibitor on GED 0301 Pharmacokinetics in Healthy Adult Subjects …
MT-0169
MT-0169 is a usion protein comprised of an enzymatically active Shiga-like toxin-I A1 subunit fused to a human single chain variable fragment with affinity for human CD38 cell surface protein.
Investigational
Matched Description: … a human single chain variable fragment with affinity for human CD38 cell surface protein. ... MT-0169 is a usion protein comprised of an enzymatically active Shiga-like toxin-I A1 subunit fused to …
TA-CIN
TA-CIN is a subunit vaccine comprising L2/E6/E7 proteins from Human Papillomavirus (HPV16), designed to generate a strong cellular immune response against HPV-infected cells.
Investigational
Matched Description: … to generate a strong cellular immune response against HPV-infected cells. ... TA-CIN is a subunit vaccine comprising L2/E6/E7 proteins from Human Papillomavirus (HPV16), designed …
Displaying drugs 2026 - 2050 of 2319 in total